|Articles|September 1, 2011
- BioPharm International-09-02-2011
- Volume 2011 Supplement
- Issue 6
BioPharm International, September 2011 Supplement (PDF)
Biopharmaceutical Trends Report
Advertisement
Articles in this issue
over 14 years ago
Q&A with Francis S. Collinsover 14 years ago
Single-use Technology: Balancing the Risks and Rewardsover 14 years ago
Challenges and Innovations with Prefilled Syringesover 14 years ago
Trends in Prefillsover 14 years ago
Perception and Costs of Biotech Innovationover 14 years ago
Navigating the Biosimilars MarketNewsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
Neurimmune and AstraZeneca Expand Efforts to Accelerate Fibril-Depleting Therapies
2
New Draft Guidance Highlights FDA Push Toward Human-Relevant Safety Models
3
New Lymphoma Indication for CAR T-Cell Therapy Shapes Pipeline
4
Regulatory Uncertainty Surfaces as FDA Blames COVID Vaccines for 10 Child Deaths
5
